<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR86">
 <label>86.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Li</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Sakamuru</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Brecher</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Koetzner</surname>
    <given-names>CA</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Qin</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>QY</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Kramer</surname>
    <given-names>LD</given-names>
   </name>
   <name>
    <surname>Menghang Xi</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>H</given-names>
   </name>
  </person-group>
  <article-title>Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease</article-title>
  <source>Antivir Res</source>
  <year>2018</year>
  <volume>2018</volume>
  <issue>150</issue>
  <fpage>217</fpage>
  <lpage>225</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2017.12.018</pub-id>
 </element-citation>
</ref>
